Logo image of BOLT

BOLT BIOTHERAPEUTICS INC (BOLT) Stock Analyst Ratings

NASDAQ:BOLT - Nasdaq - US0977021049 - Common Stock - Currency: USD

0.35  +0.02 (+5.42%)

After market: 0.36 +0.01 (+2.86%)

Buy % Consensus

48

ChartMill assigns a Buy % Consensus number of 48% to BOLT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.15. This target is 227.86% above the current price.
BOLT was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about BOLT.
In the previous month the buy percentage consensus was at a similar level.
BOLT was analyzed by 8 analysts. More opinions would make the average more meaningful.
BOLT Historical Analyst RatingsBOLT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -48 -43 -38 -33 -28 -23 -18 -13 -8 -3 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.351.011.151.151.31 - 188.57% 227.86% 227.86% 275.00%
BOLT Current Analyst RatingBOLT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-03-25 Stifel Maintains Hold -> Hold
2025-03-25 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-11-13 HC Wainwright & Co. Reiterate Neutral
2024-08-15 HC Wainwright & Co. Reiterate Neutral
2024-05-15 Leerink Partners Downgrade Outperform -> Market Perform
2024-05-15 Jones Trading Downgrade Buy -> Hold
2024-05-15 Guggenheim Downgrade Buy -> Neutral
2024-05-15 Stifel Downgrade Buy -> Hold
2024-05-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-03-22 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-03 HC Wainwright & Co. Reiterate Buy
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-26 HC Wainwright & Co. Reiterate Buy
2023-05-12 SVB Leerink Upgrade Market Perform -> Outperform
2023-05-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-30 HC Wainwright & Co. Reiterate Buy
2023-01-24 Morgan Stanley Maintains Equal-Weight
2022-10-04 HC Wainwright & Co. Initiate Buy
2022-08-11 SVB Leerink Downgrade Outperform -> Market Perform
2022-05-17 Morgan Stanley Maintains Equal-Weight
2022-01-06 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-11-10 SVB Leerink Maintains Outperform
2021-08-16 SVB Leerink Maintains Outperform
2021-05-17 SVB Leerink Maintains Outperform
2021-04-06 SVB Leerink Maintains Outperform
2021-03-02 Guggenheim Initiate Buy
2021-03-02 SVB Leerink Initiate Outperform
2021-03-02 Stifel Initiate Buy
2021-03-02 Morgan Stanley Initiate Overweight